baber/WOPTO huggingface dataset:
Patent DE-69128059-T2 (DE)
Inventor: GREENWOOD BRIAN F
IPC: D21C9/02
Filed: 1991-05-15
Granted: 1998-02-26
Abstract: A continuous solvent pulping process is practiced with oxygen free gas (e.g. nitrogen) purges of all major treatment vessels (23, 24, 85, 103, 105) during the time when the process is arrested or terminated. The wood chips or other cellulosic fibrous material to be pulped is steamed in a first horizontal steaming zone (23) at a pressure of about 10-20 psi, and then in a second horizontal steaming zone (24) at a pressure of about 20-75 psi. Gases, including vaporized solvent (e.g. ethanol or other alcohol) are vented (via 30, 36) from the steaming zones, and solvent is added (at 39) to the steamed material prior to feeding to a high pressure feeder (11) . The high pressure feeder introduces the material into the top of a single digesting vessel (12), liquid and chips being separated at the top of the digester vessel without mechanical means that could cause a spark. Lignin containing liquid is withdrawn from a central portion (14) of the digester and passed through flash tanks (51-53) and ultimately for lignin and alcohol recovery. Washing -- which also may be practiced using solvent pulp from a batch system -- is accomplished by first continuously passing the pulp to a pressure diffuser (85), then to a first multi stage drum displacer washer (103), and then to a second multi stage drum displacer washer (105). <IMAGE>   <IMAGE>   <IMAGE>
Patent DE-69132149-T2 (DE)
Inventor: BAO QI-BIN
IPC: A61F2/30
Filed: 1991-11-21
Granted: 2000-11-16
Abstract: A prosthetic nucleus for a vertebral disc is made of a hydrogel material. The hydrogel prosthetic nucleus has a shape generally conforming to the natural nucleus pulposus. The hydrogel has a water content of at least 30% and has a compressive strength of 4MNm<-><2> or greater. When the hydrogel material is dehydrated, it has a dimension of less than half of that of the hydrated hydrogel nucleus. The prosthetic nucleus may be formed of two or more pieces of hydrogel material which pieces, when combined, have a shape generally conforming to the natural nucleus. The prosthetic nucleus for implantation in the disc space after removal of a damaged or degenerated nucleus may also be formed from a multiplicity of hydrogel beads having a water content of at least 30%. The beads are covered by a semi-permeable membrane. The membrane has porosity less than the size of the beads to thereby retain the beads therein but permit fluids to flow in and out of the prosthetic nucleus. <IMAGE>
Patent DE-69201341-T2 (DE)
Inventor: ABONDANCE ROGER
IPC: A63C5/12
Filed: 1992-11-16
Granted: 1995-05-24
Abstract: Ski comprising a filling core, for example made from polyurethane foam, a shell forming the upper face and the lateral faces of the ski, a lower face equipped with longitudinal metal edges and with a central sliding running sole. According to the invention, this ski comprises two longitudinal reinforcement elements (8) extending at least in the central part of the ski, arranged on either side of the core (2), in contact both with the latter and with the parts of the inner surface of the shell (3) forming the lateral faces, each reinforcement element including a lower face extending to a large extent over the width of the corresponding edge (6), so as to provide it with an effective support, and extending over at least a part of the height of the ski.   <IMAGE>
Patent DE-69214347-T2 (DE)
Inventor: MATSUMOTO KAZUTAKE
IPC: A61B5/05
Filed: 1992-04-22
Granted: 1997-04-24
Abstract: A magnetic noise reducing device can effectively produce a practically noiseless space that can reduce environmental magnetic noise harmful for measuring biomagnetism with a high magnetism damping factor in low frequency range. The magnetic noise reducing device comprises a Superconducting Quantum Interference Devices (SQUID) flux meter 1 and a pair of noise cancelling coils 2 as minimum components, the feedback current I produced by the SQUID flux meter 1 being supplied to the noise cancelling coils 2, the magnetic flux detecting coil of the SQUID flux meter being arranged within a specific central space 4 defined by the noise cancelling coils 2 for effective reduction of magnetic noise within that space. <IMAGE>
Patent DE-69224999-T2 (DE)
Inventor: EVANS CHRISTOPHER THOMAS
IPC: C07F9/09
Filed: 1992-12-31
Granted: 1998-07-30
Abstract: PCT No. PCT/GB92/02408 Sec. 371 Date Oct. 3, 1994 Sec. 102(e) Date Oct. 3, 1994 PCT Filed Dec. 31, 1992 PCT Pub. No. WO93/15088 PCT Pub. Date Aug. 5, 1993.A process for preparing substantially dry GPC (glycerophosphocholine in enantiomeric form) from wet GPC without racemisation, comprises subjecting the wet GPC to reduced pressure and elevated temperature, to reduce the water content and give highly viscous GPC; adding ethanol or another suitable solvent and crystallising GPC therefore with cooling; filtering the crystalline GPC and removing solvent therefrom under reduced pressure; characterised in that the elevated temperature is at least 45 DEG  C.; and the solvent is added to the highly viscous GPC. This process produces an apparently new form of L- alpha -Glycerophosphocholine, m.p. 148 DEG -152 DEG  C.
Patent DE-69227609-T2 (DE)
Inventor: OLESEN SOREN-PETER
IPC: A61K31/40
Filed: 1992-08-14
Granted: 1999-04-15
Abstract: A method of treating a disease in a mammal, including a human, responsive to blockade of potassium channels, which comprises administering to a mammal in need thereof an effective amount of a compound having the formula <CHEM>  wherein R<1><1>, R<1><2>, R<1><3>, R<1><4> and R<1><5> independently of each other are hydrogen, CF3, NO2, NH2, OH, C1-6-alkyl, C1-6-alkoxy or phenyl; and R<4>, R<5>, R<6> and R<7> independently of each other are hydrogen, halogen, CF3, C1-6-alkyl, NO2, NH2, OH or C1-6-alkoxy, and a method as above wherein 1 - (4-methoxyphenyl)-indole is employed, and a method as above wherein psychotic disorders, memory disorders, Alzheimers disease or diabetes 2 is treated, and further a method as above wherein the active ingredient is administered in the form of a pharmaceutical composition thereof, in which it is present together with a pharmaceutically-acceptable carrier or diluent.
Patent DE-69231727-T2 (DE)
Inventor: CORDES HANS
IPC: B60J10/02
Filed: 1992-07-09
Granted: 2001-11-22
Abstract: Prodn. of a glass plate with a polymer frame or frame section, includes extending a profiled polymer section, using a calibrated extruder nozzle, immediately onto the edge region of the glass plate, or onto an intermediate section consisting of a glass light opaque layer and/or one or more adhesion improving layers. At least one local profile section is mechanically removed and a guide hardening polymer is injected, which forms a permanent connection with the already hardened polymer.
Patent DE-69308129-T2 (DE)
Inventor: FAIRLEY GARY
IPC: C08L35/06
Filed: 1993-03-12
Granted: 1997-08-28
Abstract: A thermoplastic polymer composition comprising a thermoplastic polyester and a polymer containing vinylaromatic monomer units and dicarboxylic acid anhydride monomer units and/or imide compounds derived therefrom, having a molecular weight of 30,000 - 200,000 g/mol, which contains at least 1 % by weight of spirodilactone monomer units. The polymer composition has improved impact strength.
Patent DE-69310865-T2 (DE)
Inventor: HAUSER JEAN-LUC
IPC: A61M5/168
Filed: 1993-04-28
Granted: 1998-01-02
Abstract: PCT No. PCT/FR93/00416 Sec. 371 Date Jun. 9, 1994 Sec. 102(e) Date Jun. 9, 1994 PCT Filed Apr. 28, 1993 PCT Pub. No. WO93/22641 PCT Pub. Date Nov. 11, 1993A device for measuring the pressure in an infusion tube (12), including a pressure sensor (20) and a housing (14) comprising at least one chamber (16) with one side defined by a deformable membrane (18) contacting the wall of the infusion tube, and containing said sensor. A fluid (24) is provided between the membrane (18) and the sensor (20). The fluid is non-liquid and has a Poisson ratio of at least 0.49 as well as an instantaneous modulus of elasticity of under 10 MPa so that the sensor response curve is linear. The device may be used in an infusion apparatus, particularly a portable infusion apparatus.
Patent DE-69312776-T2 (DE)
Inventor: CAMAGGI GIOVANNI
IPC: C07D307/58
Filed: 1993-03-20
Granted: 1998-01-15
Abstract: Compounds based on 3,4-diaryl-(5H)-furan-2-one, with fungicidal activity, having the general formula (I): <CHEM>
Patent DE-69314586-T2 (DE)
Inventor: MASUNAGA HIROAKI
IPC: A61K38/18
Filed: 1993-07-16
Granted: 1998-02-19
Abstract: Medicinal compositions comprising TCF-II derived from human fibroblast cells are particularly effective for liver disease treatment, protein synthesis stimulation and wound healing.
Patent DE-69320632-T2 (DE)
Inventor: WAYLETT JOHN E
IPC: G01N35/10
Filed: 1993-06-08
Granted: 1999-04-15
Abstract: There is described a liquid dispensing system for the transfer of liquids from one location to another. The liquid dispensing system includes a pipette in combination with a sound source and a sound detector. The liquid dispensing system can be used in combination with an automated clinical analyzer and can be utilized to provide one or more of a number of functions including sensing the proximity of a pipette tip to a surface, determining the depth to which a pipette tip has penetrated into a volume of liquid, determining whether a pipette tip has been affixed to a pipette stem and determining the amount of liquid aspirated into a pipette tip.
Patent DE-69326469-T2 (DE)
Inventor: FOSTER L
IPC: A61M16/00
Filed: 1993-07-12
Granted: 1999-12-30
Abstract: A hospital bed supported on a wheeled base, and a ventilator supported on a wheeled cart and docked to the base of the bed, the combination of ventilator and bed capable of being rolled as a single unit. The ventilator cart includes a wheeled base, and supports connected to the base for supporting a ventilator, with the supports providing for selective raising and lowering of the ventilator. The hospital bed base is wheeled and has a generally Y-shaped base frame. The outspread arms of the Y-shaped base frame receive the ventilator cart so that the two may be docked together. The ventilator when docked to the hospital bed base falls within the footprint of the bed as projected downwardly onto the floor. A latch secures the ventilator to the bed base. A disabling switch disables the high/low function of the bed preventing the bed from being lowered downwardly onto the ventilator. A power supply mounted to the bed base provides for uninterrupted operation of the ventilator. A care cart docks to the foot end of the bed and within the bed's footprint and supplies DC electricity, oxygen and air to the ventilator when the ventilator is docked to the head end of the bed. The care cart has a wheeled base, a battery housing on the base, a structure for connecting the cart to the bed base. A motorized dolley is incorporated into another embodiment of the care cart to provide motorized transport of ventilator, bed and cart.
Patent DE-69401084-T2 (DE)
Inventor: ALGERI MARIS
IPC: B30B5/02
Filed: 1994-03-11
Granted: 1997-07-10
Abstract: The die for pressing ceramic tiles makes for greater uniformity of pressing by compensating for differences of density occurring when loading the matrix with the powders to be pressed; the die (P) has a cavity closed on the side facing the clay mixture to be pressed by means of an elastic membrane (5) peripherally anchored to the body of said die (P), said elastic membrane (5) being associated to a stiffening plate (111, 316, 362, 372) the cavity may contain an incompressible fluid (11).
Patent DE-69406719-T2 (DE)
Inventor: GERBET ANDRE
IPC: G02C5/22
Filed: 1994-06-02
Granted: 1998-04-09
Abstract: The spectacles hinge comprises a first knuckle (1) integral with the face part (2) of the spectacles frame and a second knuckle (3) connected via a spring device to the side (4) of the spectacles, the said device (5) comprises a casing (10) integral with the side (4) including a longitudinal housing (11). The second knuckle (3) is integral with a prolongation (12) mounted so as to slide in the housing (11). A coil spring (16) surrounds a screw (15) of the prolongation (12) and includes one turn (19) of a diameter greater than that of the other turns and intended to engage in a groove (20) in the wall of the housing (11). The spring (16) bears, on the one hand, on this turn (19) locked in the wall of the housing (11) and, on the other hand, on the head (17) of the screw (15) in order to urge the prolongation (12) in the direction of the bottom of the housing (11) and to urge a bearing surface (26) of the casing (10) against a cam (25) integral with the first knuckle (1), thus determining open and folded-up positions of the side (4). Because of the particular shape of the end of the spring (16) interacting with the groove (20) in the housing, particularly simple construction, rapid and easy fitting and reliable operation of the spring hinge are achieved. <IMAGE>
Patent DE-69407124-T2 (DE)
Inventor: BONNAIN JEAN-CHRISTOPHE
IPC: B65B61/00
Filed: 1994-09-23
Granted: 1998-03-26
Abstract: A device for use in a machine for packaging bottles in a wraparound carton which comprises folders (12) having pivotal fingers (13,14) for engaging and folding a pair of bottle heel retention flaps (f1, f2) and to fold such flaps inwardly of the carton. The pivotal folder is adapted to execute a folding movement thereby progressively to enter an aperture in the blank to fold the flaps and to retrace therefrom during feed movement of the blank. The pivotal folder includes a follower (30) to execute the folding movement and the retracting movement. The pivotal fingers pivot upon radial movement of the folder. <IMAGE>
Patent DE-69413968-T2 (DE)
Inventor: QUIST MAGNUS
IPC: A61F13/15
Filed: 1994-05-20
Granted: 1999-03-25
Abstract: PCT No. PCT/SE94/00477 Sec. 371 Date Nov. 30, 1995 Sec. 102(e) Date Nov. 30, 1995 PCT Filed May 20, 1994 PCT Pub. No. WO94/28839 PCT Pub. Date Dec. 22, 1994An absorbent structure in an absorbent article, such as a sanitary napkin, tampon, panty protector, incontinence guard, diaper and the like, which is produced by including in the absorbent structure a polymeric foam having cells which were initially essentially closed and which has been worked so as to open said cells, and the structure has obtained liquid take up properties. The foam has a density between 0.01-0.5 g/cm3. The material has porperties which are effective in achieving the function for which the product is intended. The foam may be formed as a sheet and the sheet can be made very thin and light, with a surface weight of between 10-500 g/m2, and the article will therefore exhibit good comfort properties to the wearer and requires only a small amount of material for its manufacture.
Patent DE-69420709-T2 (DE)
Inventor: TAYLOR LARRY
IPC: H01H35/14
Filed: 1994-02-24
Granted: 2000-05-11
Abstract: With proper handling, Gallium-Indium-Tin eutectics are suitable for use as a substitute for mercury in switch applications. The eutectics should be acid washed to prevent oxidation of the metal components of the eutectic while in the switch housing and, further, the switch housing should be filled with an inert gas. Preventing oxidation ensures long term performance of the switch. In addition, provisions need to be made to prevent wetting of the switch housing by the eutectic. Experiments have shown that acid washing of metallic switch housings prior to adding the Gallium-Indium-Tin eutectic reduces or eliminates wetting by the eutectic. In addition, experiments have shown that coating the walls of the switch housing with a fluoropolymer coating prevents wetting by the eutectic.
Patent DE-69423355-T2 (DE)
Inventor: SUONVIERI JUKKA
IPC: H04J3/06
Filed: 1994-06-30
Granted: 2000-07-27
Abstract: PCT No. PCT/FI94/00302 Sec. 371 Date Jan. 5, 1996 Sec. 102(e) Date Jan. 5, 1996 PCT Filed Jun. 30, 1994 PCT Pub. No. WO95/02307 PCT Pub. Date Jan. 19, 1995In a digital time division multiple access (TDMA) radio system, the transmission times of mobile stations in a cell are advanced in relation to the base station of the cell each by a timing advance which compensates for the transmission delay caused by the distance between the base station and the respective mobile station. Part of the radio capacity of the cell is arranged to serve only within a first given timing advance range, and thereby to serve mobile stations located within a first given area of the cell, and another part of the radio capacity is arranged to serve only within a second given timing advance range, which is different from the first timing advance range, and thereby to serve mobile stations located with a second given area of the cell. The first and second areas may partially overlap. Handoffs between channels of the capacity are accomplished on the basis of exceeding or falling below threshold timing advance values.
Patent DE-69426722-T2 (DE)
Inventor: IMLER JEAN-LUC
IPC: A61K48/00
Filed: 1994-05-27
Granted: 2001-09-20
Abstract: New replication-defective adenoviruses are selected from: (a) those that are derived from a natural adenovirus and lack at least the coding sequences of the E1B region and/or at least part of the E4 region; (b) those that are derived from a natural adenovirus other than a human type 5 adenovirus (Ad5) and lack part of the encapsidation region; (c) those that are derived from Ad5 and lack the part of the encapsidation region corresp. to nucleotides 270-346 in the Genbank M73260 sequence; and (d) those that are derived from Ad5 and lack the part of the encapsidation region corresp. to nucleotides 184-273 in the Genbank M73260 sequence. Also claimed is a eukaryotic cell contg. an adenovirus as above. Also claimed are: (1) a complementation line comprising a cell line contg. a complementation element which comprises at least part of the E1 region of a natural adenovirus and lacks the 5' ITR sequence, the element being integrated into the genome or inserted into a vector: and (2) a process for producing a defective adenovirus as above, comprising introducing the virus into a complementation line as above, culturing the cell line, and recovering the virus from the culture supernatant.
Patent DE-69427906-T2 (DE)
Inventor: SCHOCK B
IPC: A61H31/00
Filed: 1994-03-11
Granted: 2002-04-04
Abstract: An active compression/decompression CPR device capable of providing both complete cardiopulmonary support and cardiopulmonary assistance includes two or more thoracic compressors, preferably inflatable bladders, positioned so that the chest can first be flattened and compressed, increasing the pressure in the chest, and then circularized and decompressed, decreasing the pressure in the chest. When inflatable bladders are used, they can be surrounded with a rigidifying vest which resists outward bladder expansion. Compression and decompression can be performed along with abdominal compression, and the device is capable of shifting between support and assist modes when the patient's condition so requires. Also described is a method of compressing and then decompressing a patient's thorax by applying anterior and/or posterior pressure to the thorax, so as to compress the thorax and increase pressure therein, relieving that pressure, and then applying lateral pressure to the thorax to decompress and relieve pressure in the thorax, and then relieving the lateral pressure.
Patent DE-69429880-T2 (DE)
Inventor: COZZI SERAFINO
IPC: B21D1/05
Filed: 1994-12-05
Granted: 2002-11-28
Abstract: PCT No. PCT/IT94/00205 Sec. 371 Date Apr. 9, 1997 Sec. 102(e) Date Apr. 9, 1997 PCT Filed Dec. 5, 1994 PCT Pub. No. WO96/14175 PCT Pub. Date May 17, 1996Flattening group (18) for levelling machine with operative rollers (60-65, 70-74) of increasing diameter.
Patent DE-69432827-T2 (DE)
Inventor: ATHEY PATRICIA RUZAKOWSKI
IPC: C23C16/455
Filed: 1994-02-10
Granted: 2004-05-19
Abstract: Glass coated with metal oxides. A coating mixture includes tin containing precursors and a silicon containing precursor. The silicon containing precursor ha the structural formula <CHEM> Wherein R1 is a group which does not have an oxygen available to form a peroxide, R2 is a functional group giving the silicon containing precursor the ability to be easily converted to silicon oxide coating, R3 is a bridging group to provide for multiple silicon atoms and R4 completes the bonding on the foundation silicon atom. As accelerant e.g. phosphorus containing precursor may be used with the metal containing precursor to increase the deposition rate of the coating. The coating deposited on the glass has regions of continuously varying weight percent of silicon oxide and tin oxide as the distance from the glass-coating interface increases, with the surface of the coating farthest from the glass-coating interface being predominantly tin oxide.
Patent DE-69434992-T2 (DE)
Inventor: BENEDETTI LUCA
IPC: A61L26/00
Filed: 1994-07-29
Granted: 2007-12-06
Abstract: The present invention is drawn to a pharmaceutical composition, comprising a pharmaceutically effective amount of an acidic polysaccharide and/or a derivative thereof, a gaseous vehicle, and a pharmaceutically acceptable carrier or excipient. Said acidic polysaccharide or derivative thereof can be hyaluronic acid, a pharmaceutically acceptable salt of hyaluronic acid, a partial or total ester of hyaluronic acid with an alcohol, a partial or total intermolecular ester of hyaluronic acid, a partial or total intramolecular ester of hyaluronic acid, a cross-linked ester of hyaluronic acid, an alginic acid ester, an ester of carboxymethylcellulose, an ester of carboxymethylchitin, an ester of carboxymethyl starch, a gellan ester, a cross-linked gellan ester, a pectic acid ester, and a pectinic acid ester. The composition can contain one or more topical drugs, and can be in the form of an aerosol or liquid spray, a foam, or a dry spray. The composition is useful in the treatment of a variety of pathological situations requiring the acceleration of tissue repair, for example in the treatment of burns, sores, ulcerations, and wounds. Also provided is a therapeutic method, comprising topically administering a pharmaceutical composition comprising a pharmaceutically effective amount of an acidic polysaccharide and/or a derivative thereof in association with a gaseous vehicle and a pharmacologically acceptable excipient, and optionally, one or more topical drugs.
Patent DE-69500060-T2 (DE)
Inventor: LION BERTRAND
IPC: A61K8/00
Filed: 1995-05-10
Granted: 1997-02-13
Abstract: The present application relates to a cosmetic composition, in particular a care or make-up composition to be applied to the skin and/or to the eyelashes, which comprises at least one fatty substance and at least one aqueous polymer dispersion consisting of particles resulting from the polymerization of a radical monomer in the interior and/or partially at the surface of already existing polymer particles of polyester type.
Patent DE-69506157-T2 (DE)
Inventor: MIKLER CLAUDE
IPC: A61K9/70
Filed: 1995-03-15
Granted: 1999-07-01
Abstract: Self-adhesive transdermal matrix material for percutaneous admin. of hormones comprises (1) a support and (2) a self-adhesive matrix comprising (by wt.): (a) 20-42 pts. triblock poly(styrene-isoprene-styrene) (SIS) copolymer; (b) 35-55 pts. tackifying resin (TR); (c) 5-25 pts. plasticiser, i.e. oleyl alcohol, peglicol-5-oleate, propyleneglycol laurate (PGL) or polypropoxylated cetyl alcohol; (d) 5-15 pts. crotamiton and/or an N-substd. 2-pyrrolidone deriv. (I); (e) 0.01-1 pt. stabiliser and (f) 0.1-5 pts. oestrogenic and/or progestational hormones.